Mps1-IN-1 dihydrochloride is used as a potent, selective, and ATP-competitive inhibitor of Mps1 kinase for research applications, including the study of mitotic checkpoint regulation, disruption of Mad2 recruitment to kinetochores, reduction of Aurora B phosphorylation at Thr232, induction of checkpoint bypass in mitotic arrest (e.g., in U2OS cells), and suppression of proliferation in cancer cell lines such as HCT116.